Robert Stefanovich - 12 Mar 2026 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Reporting relationship: Chief Financial Officer
Issuer ticker: CYRX
Reported as of: 12 Mar 2026
Net transaction value: -$322,330
SEC form: 4
Accepted by SEC: 16 Mar 2026, 21:35:53 UTC
Prior SEC filing: 21 Aug 2025
Next SEC filing: 25 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Robert Stefanovich

Key filing fact

Robert Stefanovich filed Form 4 for Cryoport, Inc. (CYRX) on 16 Mar 2026.

Key facts

This page summarizes Robert Stefanovich's Form 4 filing for Cryoport, Inc. (CYRX).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 16 Mar 2026, 21:35.

Change

Previous filing in this sequence was filed on 21 Aug 2025.
Current net transaction value: -$322,330.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001247309 Primary reporting owner

STEFANOVICH ROBERT

Relationship: Chief Financial Officer
Address: C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD
Signature: /s/ Robert Stefanovich
Signature date: 16 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYRX transaction

Common Stock

Options Exercise

Transaction value
Shares: +87,188
Change %: +42%
Price: $1.87^*
Shares after: 294,401
Date: 12 Mar 2026
Ownership: Direct

CYRX transaction

Common Stock

Sale

Transaction value: $300,386
Shares: -38,700
Change %: -13%
Price: $7.76
Shares after: 255,701
Date: 12 Mar 2026
Ownership: Direct
Footnotes: F1, F2

CYRX transaction

Common Stock

Award

Transaction value
Shares: +27,413
Change %: +11%
Price: $0.000000^*
Shares after: 283,114
Date: 14 Mar 2026
Ownership: Direct
Footnotes: F3

CYRX transaction

Common Stock

Sale

Transaction value: $21,944
Shares: -2,743
Change %: -0.97%
Price: $8.00
Shares after: 280,371
Date: 16 Mar 2026
Ownership: Direct
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYRX transaction Derivative

Options to purchase common stock

Options Exercise

Transaction value
Shares: -87,188
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 12 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 87,188
Exercise price: $1.87
Footnotes: F5

CYRX transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +82,240
Change %
Price: $0.000000^*
Shares after: 82,240
Date: 14 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 82,240
Exercise price: $8.60
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.

Footnote F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.725 to $7.83, inclusive.

Footnote F3

Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.

Footnote F4

Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

Footnote F5

1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016.

Footnote F6

1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.

SEC remarks

With respect to prices reported as weighted average prices in Table I, the reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4.